- Genomic evidence for reinfection with different Omicron subvariants.
Hirotsu Y, Omata M.
J Infect. 2023:S0163-4453(23)00010-5.
- Validity of pathological diagnosis for early colorectal cancer in genetic background.
Okimoto K, Hirotsu Y, Arai M, Amemiya K, Akizue N, Ohta Y, Taida T, Saito K, Ohyama H, Matsumura T, Nishimura M, Matsushita K, Matsusaka K, Oyama T, Mochizuki H, Chiba T, Kato J, Ikeda JI, Yokosuka O, Kato N, Omata M.
Cancer Med. 2023;12(7):8490-8498.
- Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2.
Hirotsu Y, Kakizaki Y, Saito A, Tsutsui T, Hanawa S, Yamaki H, Ide S, Kawaguchi M, Kobayashi H, Miyashita Y, Omata M.
Commun Med (Lond). 2023;3(1):32.
- Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile.
Ohyama H, Hirotsu Y, Amemiya K, Miura Y, Hirose S, Oyama T, Iimuro Y, Kojima Y, Mikata R, Mochizuki H, Kato N, Omata M.
Cancer. 2023;129(11):1714-1722.
- Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination.
Hirotsu Y, Sugiura H, Takatori M, Mochizuki H, Omata M.
Microbiol Spectr. 2023;11(3):e0131623.
- Carcinogenic potential in regenerated mucosa after endoscopic resection of esophageal squamous cell carcinoma.
Akizue N, Okimoto K, Hirotsu Y, Amemiya K, Kaneko T, Ohta Y, Taida T, Saito K, Matsumura T, Nishimura M, Matsushita K, Mochizuki H, Chiba T, Arai M, Kato J, Omata M, Kato N.
J Gastroenterol Hepatol. in press
- Nucleic Acid Quality Assessment is Critical to the Success of the Oncomine Dx Target Test for Lung Cancer.
Nagakubo Y, Hirotsu Y, Amemiya K, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Higuchi R, Nakagomi T, Goto T, Oyama T, Omata M.
Mol Diagn Ther. 2023;27(4):513-523.
- Impact of the FilmArray Rapid Multiplex PCR Assay on Clinical Outcomes of Patients with Bacteremia.
Okamoto M, Maejima M, Goto T, Mikawa T, Hosaka K, Nagakubo Y, Hirotsu Y, Amemiya K, Sueki H, Omata M.
Diagnostics (Basel). 2023;13(11):1935.
- Genetic dissection of intratumor heterogeneity of PD-L1 expression in EGFR-mutated lung adenocarcinoma.
Kunimasa K, Hirotsu Y, Amemiya K, Honma K, Nakamura H, Nishino K, Omata M.
Thorac Cancer. 2023;14(22):2210-2215.
- p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?
Sakamoto I, Kagami K, Nozaki T, Hirotsu Y, Amemiya K, Oyama T, Omata M.
Am J Surg Pathol. in press
